A detailed history of Capital Research Global Investors transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Capital Research Global Investors holds 2,614,308 shares of BBIO stock, worth $72.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,614,308
Previous 2,212,085 18.18%
Holding current value
$72.6 Million
Previous $56 Million 18.79%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$23.91 - $31.3 $9.62 Million - $12.6 Million
402,223 Added 18.18%
2,614,308 $66.6 Million
Q1 2024

May 14, 2024

BUY
$27.35 - $40.45 $30.4 Million - $45 Million
1,111,975 Added 101.08%
2,212,085 $68.4 Million
Q3 2023

Nov 13, 2023

BUY
$16.89 - $35.01 $18.6 Million - $38.5 Million
1,100,110 New
1,100,110 $29 Million

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.12B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Capital Research Global Investors Portfolio

Follow Capital Research Global Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.